» Articles » PMID: 31907381

The Genetics of Bipolar Disorder

Overview
Journal Mol Psychiatry
Date 2020 Jan 8
PMID 31907381
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Bipolar disorder (BD) is one of the most heritable mental illnesses, but the elucidation of its genetic basis has proven to be a very challenging endeavor. Genome-Wide Association Studies (GWAS) have transformed our understanding of BD, providing the first reproducible evidence of specific genetic markers and a highly polygenic architecture that overlaps with that of schizophrenia, major depression, and other disorders. Individual GWAS markers appear to confer little risk, but common variants together account for about 25% of the heritability of BD. A few higher-risk associations have also been identified, such as a rare copy number variant on chromosome 16p11.2. Large scale next-generation sequencing studies are actively searching for other alleles that confer substantial risk. As our understanding of the genetics of BD improves, there is growing optimism that some clear biological pathways will emerge, providing a basis for future studies aimed at molecular diagnosis and novel therapeutics.

Citing Articles

The Potential of Selected Plants and Their Biologically Active Molecules in the Treatment of Depression and Anxiety Disorders.

Urbanska N, Ashaolu T, Mattova S, Simko P, Kiskova T Int J Mol Sci. 2025; 26(5).

PMID: 40076986 PMC: 11900588. DOI: 10.3390/ijms26052368.


The Balance in the Head: How Developmental Factors Explain Relationships Between Brain Asymmetries and Mental Diseases.

Manns M, Juckel G, Freund N Brain Sci. 2025; 15(2).

PMID: 40002502 PMC: 11852682. DOI: 10.3390/brainsci15020169.


Human mood disorder risk gene Synaptotagmin-14 contributes to mania-like behaviors in mice.

Zhang Y, Zhang C, Yuan J, Jiang H, Sun P, Hui L Mol Psychiatry. 2025; .

PMID: 39966626 DOI: 10.1038/s41380-025-02933-1.


NEK4: prediction of available drug targets and common genetic linkages in bipolar disorder and major depressive disorder.

Gong B, Xiao C, Feng Y, Shen J Front Psychiatry. 2025; 16:1414015.

PMID: 39950180 PMC: 11821612. DOI: 10.3389/fpsyt.2025.1414015.


Heterogeneity analysis provides evidence for a genetically homogeneous subtype of bipolar-disorder.

McGrouther C, Rangan A, Di Florio A, Elman J, Schork N, Kelsoe J PLoS One. 2025; 20(1):e0314288.

PMID: 39879180 PMC: 11778664. DOI: 10.1371/journal.pone.0314288.


References
1.
Merikangas K, Jin R, He J, Kessler R, Lee S, Sampson N . Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011; 68(3):241-51. PMC: 3486639. DOI: 10.1001/archgenpsychiatry.2011.12. View

2.
McMahon F, Stine O, Chase G, Meyers D, Simpson S, DePaulo Jr J . Influence of clinical subtype, sex, and lineality on age at onset of major affective disorder in a family sample. Am J Psychiatry. 1994; 151(2):210-5. DOI: 10.1176/ajp.151.2.210. View

3.
Simon N, Otto M, Wisniewski S, Fossey M, Sagduyu K, Frank E . Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2004; 161(12):2222-9. DOI: 10.1176/appi.ajp.161.12.2222. View

4.
Deckersbach T, Peters A, Sylvia L, Urdahl A, Magalhaes P, Otto M . Do comorbid anxiety disorders moderate the effects of psychotherapy for bipolar disorder? Results from STEP-BD. Am J Psychiatry. 2013; 171(2):178-86. PMC: 3946300. DOI: 10.1176/appi.ajp.2013.13020225. View

5.
Merikangas K, Mehta R, Molnar B, Walters E, Swendsen J, Bijl R . Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict Behav. 1998; 23(6):893-907. DOI: 10.1016/s0306-4603(98)00076-8. View